Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.

Cerebral Cortex
Harvey M MorrisDavid A Lewis

Abstract

Alterations in the inhibitory circuitry of the dorsolateral prefrontal cortex (DLPFC) in schizophrenia include reduced expression of the messenger RNA (mRNA) for somatostatin (SST), a neuropeptide present in a subpopulation of gamma-aminobutyric acid (GABA) neurons. However, neither the cellular substrate nor the causal mechanisms for decreased SST mRNA levels in schizophrenia are known. We used in situ hybridization to quantify the compartmental, laminar, and cellular levels of SST mRNA expression in the DLPFC of 23 pairs of schizophrenia or schizoaffective disorder and control subjects. We also explored potential causal mechanisms by utilizing similar methods to analyze SST mRNA expression in 2 animal models. The expression of SST mRNA was significantly decreased in layers 2-superficial 6 of subjects with schizophrenia, but not in layer 1, deep 6 or the white matter. At the cellular level, both the density of cortical SST mRNA-positive neurons and the expression of SST mRNA per neuron were reduced in the subjects with schizophrenia. These alterations were not due to potential confounds and appeared to be a downstream consequence of impaired neurotrophin signaling through the trkB receptor. These findings support the hypothesi...Continue Reading

References

Jan 1, 1990·Experimental Neurology·S A Bayer, J Altman
Oct 1, 1994·Biological Psychiatry·M Fink
Jan 1, 1994·The Journal of Neuropsychiatry and Clinical Neurosciences·P S Goldman-Rakic
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·A Da CunhaL E Eiden
Sep 1, 1997·Cerebral Cortex·Y Kawaguchi, Y Kubota
Apr 9, 1999·Nature Neuroscience·A ReyesB Sakmann
Nov 9, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·C M KrauseH Hämäläinen
Apr 5, 2001·Journal of Psychiatric Research·J J ThuneB Pakkenberg
Oct 13, 2001·Brain Research. Molecular Brain Research·G VilluendasL Cacicedo
Jan 23, 2002·Molecular Psychiatry·M MallatV Moura Neto
Feb 12, 2002·Nature Neuroscience·Beatriz RicoLouis F Reichardt
Apr 5, 2003·Journal of Neurochemistry·José VelaDiego Ruano
Jan 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·X-J WangP S Goldman-Rakic
Aug 20, 2004·Journal of Neurophysiology·Jay R GibsonBarry W Connors
Jan 14, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Takanori HashimotoDavid A Lewis
Feb 5, 2005·Biological Psychiatry·E Fuller TorreyMichael B Knable
Aug 16, 2005·Brain Research. Developmental Brain Research·Gisela GrosseHeide Hörtnag
Sep 24, 2005·The Journal of Neuropsychiatry and Clinical Neurosciences·Henry Silver, Pablo Feldman
Oct 4, 2005·The American Journal of Psychiatry·Hao-Yang TanMichael W L Chee

❮ Previous
Next ❯

Citations

Oct 1, 2008·Indian Journal of Clinical Biochemistry : IJCB·N GaurS Mishra
Oct 17, 2012·Molecular Psychiatry·C S WeickertT W Weickert
Jun 17, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jill R Glausier, David A Lewis
Apr 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Daisuke H TanakaKazunori Nakajima
Aug 4, 2011·Cerebral Cortex·David W VolkDavid A Lewis
Jul 29, 2011·Schizophrenia Bulletin·Jenny WongCynthia Shannon Weickert
Apr 3, 2009·The Journal of Clinical Investigation·David A Lewis, Robert A Sweet
May 1, 2012·PloS One·Vibeke Sørensen Catts, Cynthia Shannon Weickert
Feb 25, 2014·Pharmacology & Therapeutics·Catherine L WinchesterBrian J Morris
Nov 12, 2013·Biological Psychiatry·Benjamin I SiegelDavid W Volk
Oct 7, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Udani RatnayakeMaarten van den Buuse
Jul 9, 2013·Biological Psychiatry·Samantha J FungCynthia Shannon Weickert
Dec 4, 2014·Schizophrenia Research·David W VolkDavid A Lewis
Jan 15, 2015·Schizophrenia Research·Samuel M CohenMichael M Halassa
Dec 4, 2012·Neurobiology of Disease·Melis InanStewart A Anderson
Jun 18, 2011·Current Opinion in Neurobiology·David A LewisGuillermo Gonzalez-Burgos
Jan 15, 2011·Neurobiology of Disease·Adam TrippEtienne Sibille
Jul 15, 2009·Progress in Neurobiology·Jacques EpelbaumCécile Viollet
Sep 20, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ryan J DuchatelPaul A Tooney
Jan 15, 2010·Journal of Neurochemistry·Matthew James GirgentiSamuel Sathyanesan Newton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.